(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 21192.40 | 17469.00 | 21.31 | 21192.40 | 17469.00 | 21.31 | 73367.50 | 66779.20 | 9.87 |
| Other Income | 174.20 | 250.20 | -30.38 | 174.20 | 250.20 | -30.38 | 946.40 | 712.90 | 32.75 |
| PBIDT | 5950.60 | 4319.40 | 37.76 | 5950.60 | 4319.40 | 37.76 | 18749.30 | 15963.20 | 17.45 |
| Interest | 50.40 | 120.60 | -58.21 | 50.40 | 120.60 | -58.21 | 435.10 | 630.40 | -30.98 |
| PBDT | 5900.20 | 4198.80 | 40.52 | 5900.20 | 4198.80 | 40.52 | 18010.00 | 12517.40 | 43.88 |
| Depreciation | 746.10 | 631.30 | 18.18 | 746.10 | 631.30 | 18.18 | 2688.70 | 2519.70 | 6.71 |
| PBT | 5154.10 | 3567.50 | 44.47 | 5154.10 | 3567.50 | 44.47 | 15321.30 | 9997.70 | 53.25 |
| TAX | 1421.20 | 947.10 | 50.06 | 1421.20 | 947.10 | 50.06 | 3996.10 | 3490.10 | 14.50 |
| Deferred Tax | 120.00 | 20.50 | 485.37 | 120.00 | 20.50 | 485.37 | -25.10 | 81.10 | -130.95 |
| PAT | 3732.90 | 2620.40 | 42.46 | 3732.90 | 2620.40 | 42.46 | 11325.20 | 6507.60 | 74.03 |
| Equity | 253.70 | 253.70 | 0.00 | 253.70 | 253.70 | 0.00 | 253.70 | 253.70 | 0.00 |
| PBIDTM(%) | 28.08 | 24.73 | 13.56 | 28.08 | 24.73 | 13.56 | 25.56 | 23.90 | 6.91 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1921.90 |
| Dr. Reddys Labs. | 1200.30 |
| Cipla | 1450.00 |
| Lupin | 2235.00 |
| Zydus Lifesciences | 1140.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: